Cedars-Sinai Medical Center: Prostatic Neoplasms trials

The registry lists 12 Prostatic Neoplasms studies with Cedars-Sinai Medical Center as lead sponsor. 4 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 2 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)RecruitingNCT07223385Phase 2
• RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate CancerRecruitingNCT06856694Not applicable
• Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate CancerRecruitingNCT06437574Phase 2
• NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision MakingRecruitingNCT05923684Not applicable
• Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on TherapyCompletedNCT03418324Phase 2Results posted
• High Resolution MRI Study for Prostate CancerCompletedNCT03292874Not applicableResults posted
• The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
• Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer PatientsActive, not recruitingNCT04575402
• Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active SurveillanceCompletedNCT03679260Phase 2
• Patient-Centered Communication of Life Expectancy Estimates in Genitourinary MalignanciesStatus unknownNCT03522155Not applicable
• Cellular Effect of Cholesterol-Lowering Prior to Prostate RemovalCompletedNCT02534376Early Phase 1
• A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNCT00672009Phase 2